Correction to: Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks

John Stekelenborg (), Vijay Kara, Roman Haack, Ulrich Vogel, Anju Garg, Markus Krupp, Kate Gofman, Brian Dreyfus, Manfred Hauben and Andrew Bate
Additional contact information
John Stekelenborg: Janssen, the Pharmaceutical Companies of Johnson & Johnson
Vijay Kara: GSK
Roman Haack: Bayer AG, Pharmacovigilance Analytics
Ulrich Vogel: Boehringer Ingelheim International GmbH
Anju Garg: Sanofi
Markus Krupp: Merck Healthcare KGaA
Kate Gofman: AstraZeneca
Brian Dreyfus: Bristol-Myers Squibb Company
Manfred Hauben: Pfizer Inc
Andrew Bate: GSK

Drug Safety, 2023, vol. 46, issue 3, No 10, 325-325

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-023-01272-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:46:y:2023:i:3:d:10.1007_s40264-023-01272-w

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-023-01272-w

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().